211 results on '"Koeppen, Michael"'
Search Results
2. Semaphorin 7A coordinates neutrophil response during pulmonary inflammation and sepsis
3. Early vvECMO implantation may be associated with lower mortality in ARDS
4. COVID-19 does not influence functional status after ARDS therapy
5. Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
6. Blutungsrisiko im Kanülenbereich bei physiotherapeutischer Mobilisation unter extrakorporaler Membranoxygenierung: Eine retrospektive Analyse bei Patient*innen mit akutem Lungenversagen
7. COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
8. Patient-Related Factors Associated with Adverse Outcomes Following Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation
9. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
10. Neuronal guidance proteins in cardiovascular inflammation
11. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort
12. The Intriguing Role of Hypoxia-Inducible Factor in Myocardial Ischemia and Reperfusion: A Comprehensive Review
13. Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb
14. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
15. Needle-free connectors catheter-related bloodstream infections: a prospective randomized controlled trial
16. Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion
17. Echocardiography as a Tool to Assess Cardiac Function in Critical Care—A Review
18. Membrane oxygenator longevity was higher in Argatroban treated patients undergoing vvECMO
19. Additional file 1 of Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
20. Additional file 3 of COVID-19 does not influence functional status after ARDS therapy
21. Additional file 1 of COVID-19 does not influence functional status after ARDS therapy
22. Additional file 2 of COVID-19 does not influence functional status after ARDS therapy
23. Additional file 4 of COVID-19 does not influence functional status after ARDS therapy
24. Corrigendum: Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study
25. Dynamic of SOFA Score Predicts Functionality after ARDS Therapy
26. Methylene blue dosing strategies in critically ill adults with shock—A retrospective cohort study
27. Blutungsrisiko im Kanülenbereich bei physiotherapeutischer Mobilisation unter extrakorporaler Membranoxygenierung
28. Purinergic Regulation of Airway Inflammation
29. Myeloid hypoxia-inducible factor HIF1A provides cardio-protection during ischemia and reperfusion via induction of netrin-1
30. Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury
31. Inhaled Prostacyclin Improves Oxygenation in Patients with COVID-19-induced Acute Respiratory Distress Syndrome – a randomized controlled multicenter trial
32. Perioperative Echokardiografie der rechts- und linksventrikulären Funktion
33. Journey Through America
34. Control of Neutrophil activation through Semaphorin 7A-Plexin C1 is essential for immune defense during pulmonary sepsis
35. COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
36. Circadian Rhythms in Anesthesia and Critical Care Medicine: Potential Importance of Circadian Disruptions
37. sj-docx-1-cra-10.1177_1179548421992327 – Supplemental material for COVID-19 Related Cardiovascular Comorbidities and Complications in Critically Ill Patients: A Systematic Review and Meta-analysis
38. Machine Learning Identifies ICU Outcome Predictors in a Multicenter COVID-19 Cohort.
39. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort
40. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
41. Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
42. COVID-19 Related Cardiovascular Comorbidities and Complications in Critically Ill Patients: A Systematic Review and Meta-analysis
43. Supplemental Material, R1_-_Supplement_1 - Extubation and Noninvasive Ventilation of Patients Supported by Extracorporeal Life Support for Cardiogenic Shock: A Single-Center Retrospective Observational Cohort Study
44. Additional file 1 of Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
45. Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection
46. Purinergic Regulation of Airway Inflammation
47. Myocardial Ischemia Reperfusion Injury: From Basic Science to Clinical Bedside
48. The hypoxia–inflammation link and potential drug targets
49. Extubation and Noninvasive Ventilation of Patients Supported by Extracorporeal Life Support for Cardiogenic Shock: A Single-Center Retrospective Observational Cohort Study
50. Early Driving Pressure Changes Predict Outcomes during Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.